ANDA 75045, held by Hikma. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 75045 (Butorphanol Tartrate Preservative Free), held by Hikma, was first approved by FDA on Aug 12, 1998, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 12, 1998 | Original application | Approved |
| Butorphanol Tartrate Preservative Free1MG/ML · injectable;injection | Butorphanol Tartrate | Rx |
| Butorphanol Tartrate Preservative Free2MG/ML · injectable;injection | Butorphanol Tartrate | Rx |
| Dec 22, 2025 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jan 10, 2024 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jan 10, 2024 | Supplement 17Labeling · Standard review | Approved | None posted |
| Oct 11, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 30, 2001 | Supplement 3Labeling | Approved | None posted |
| Apr 3, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Oct 15, 1999 | Supplement 1Labeling | Approved | None posted |
| Aug 12, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters